Published in J Res Med Sci on May 01, 2012
Predicting increased blood pressure using machine learning. J Obes (2014) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA (2003) 7.35
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
Regulation of fasted blood glucose by resistin. Science (2004) 3.54
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 3.50
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation (2004) 2.90
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem (2001) 2.09
Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab (2010) 1.74
Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. Am J Physiol Cell Physiol (2009) 1.57
Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol (2010) 1.54
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypertension. Am J Hypertens (2010) 1.44
Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol (2005) 1.40
C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care (2004) 1.33
Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes (2008) 1.13
Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res (2011) 0.98
Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest (2007) 0.97
Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab (2002) 0.94
Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Endocrinology (2003) 0.93
The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med (2010) 0.89
Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease. Am J Cardiol (2011) 0.88
Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis (2011) 0.87
Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol (2010) 0.87
Adipokines and cardiometabolic function: How are they interlinked? Regul Pept (2010) 0.86
Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling. Clin Exp Pharmacol Physiol (2010) 0.84
Serum resistin: physiology, pathophysiology and implications for heart failure. Biomark Med (2010) 0.81
Clinical practice: proteinuria. Eur J Pediatr (2010) 0.79
[Microalbuminuria. From diabetes to cardiovascular risk]. Vnitr Lek (2011) 0.77
[Prevalence of microalbuminuria and its clinical correlation with other risk factors of cardiovascular diseases]. Orv Hetil (2010) 0.77
Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia. J Res Med Sci (2011) 0.88
Predictive value of Berlin Questionnaire and Epworth Sleepiness Scale for obstructive sleep apnea in a sleep clinic population. Clin Respir J (2014) 0.84
Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatol Int (2014) 0.83
Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers. J Res Med Sci (2011) 0.83
Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients. J Korean Med Sci (2007) 0.83
Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. J Res Med Sci (2012) 0.75
The relation of obesity with serum resistin levels in smoker and nonsmokers. J Res Med Sci (2012) 0.75
The effect of ursodeoxycholic acid treatment on epidermal growth factor in patients with bile reflux gastritis. Turk J Gastroenterol (2002) 0.75